The global rapid infuser market is set to enjoy a valuation of US$ 1.01 Bn in 2022, and further expand at a CAGR of 4.6% to reach US$ 1.52 Bn by the year 2031.

MACON, Ga.--(BUSINESS WIRE)--Smisson-Cartledge Biomedical LLC, an ISO 13485:2016 certified manufacturer of the ThermaCor 1200 Rapid Infuser technology for use in a broad spectrum of medical ...

Global Rapid infuser Market is valued approximately at USD 789.37 million in 2019 and is anticipated to grow with a CAGR of more than 3.5% over the forecast period 2020-2027. Rapid infusers are a ...

DURHAM – Durham’s 410 Medical, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration clearance in 2020.